Scibase AB 

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Nevisense; Vrije Universiteit Brussel University hospitals for a study geared toward predicting atopic dermatitis and concomitant atopic diseases, such as asthma and hay fever in infants. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.